Dharshana Sabanayagam

ORCID: 0000-0002-6650-7002
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Chronic Kidney Disease and Diabetes
  • Renal Transplantation Outcomes and Treatments
  • Pregnancy and Medication Impact
  • Renal and Vascular Pathologies
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmacological Effects and Toxicity Studies
  • Blood Pressure and Hypertension Studies
  • Chronic Disease Management Strategies
  • Healthcare cost, quality, practices
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • Healthcare Policy and Management
  • Acute Kidney Injury Research
  • Organ Transplantation Techniques and Outcomes
  • COVID-19 Clinical Research Studies

The University of Sydney
2022-2025

Westmead Hospital
2022-2024

Children's Hospital at Westmead
2022-2024

This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this are those the authors and do not necessarily reflect recommendations International Society Nephrology Elsevier. Dosages, indications, methods use for products that referred to may their clinical experience be derived from professional literature other sources.

10.1016/j.kint.2023.10.018 article EN cc-by-nc-nd Kidney International 2024-03-13

The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Disease (CKD) updates KDIGO 2012 guideline has been developed with patient partners, clinicians, researchers around world, using robust methodology. This update, based on a substantially broader base evidence than previously available, reflects an exciting time in nephrology. New therapies strategies have tested large diverse populations that help to inform care;...

10.1016/j.kint.2023.10.016 article EN cc-by-nc-nd Kidney International 2024-03-20

Since November 2021, a new variant of concern (VOC), the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage B.1.1.529 (Omicron) has emerged as dominant disease 2019 (COVID-19) infection worldwide. We describe clinical presentation, risk factors, and outcomes in cohort kidney pancreas transplant recipients with COVID-19 caused by Omicron infection.We included all diagnosed SARS-CoV-2 infections between December 26, January 14, 2022, single center Australia. Identification...

10.1097/tp.0000000000004203 article EN Transplantation 2022-06-08

Introduction. Home dialysis modalities offer several clinical and economic benefits compared to facility-based treatment in patients with kidney failure. Studies have shown that sex socioeconomic status (SES) disparities exist access transplantation failure, but whether similar occur the home after transplant failure is unknown. Methods. Using data from ANZDATA registry, who commenced Australia were included (2000-2020). The associations between uptake of peritoneal (PD) haemodialysis (HHD)...

10.1159/000543788 article EN American Journal of Nephrology 2025-02-26
Coming Soon ...